Alzheimer Disease Clinical Trials in Los Alamitos, California

3 studies are recruiting for alzheimer disease in Los Alamitos, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

    The purpose of this Master Protocol is to support multiple studies looking at safety and tolerability of different drugs in healthy participants and participants with Alzheimer's disease, and if they remove clumps of protein (amyloid plaque) in the brain in participants with Alzheimer's Disease. Pa…

    Stage
    Phase 1
    Ages
    18 to 85
    Site
    Collaborative Neuroscience Network - CNS, Los Alamitos, California
    Locations
    18 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07787169 on ClinicalTrials.gov

  2. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.

    Stage
    Phase 2
    Ages
    55 and older
    Site
    Pharmacology Research Institute, Los Alamitos, California
    Locations
    69 in total
    Run by
    Intra-Cellular Therapies, Inc.

    See if you can join NCT06540833 on ClinicalTrials.gov

  3. A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

    The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY4006895. Part A will administer a single-ascending dose in healthy participants or Part B will administer multiple-ascending doses in participants with early symptomatic Alzheimer's Disease (AD). …

    Stage
    Phase 1
    Ages
    45 to 85
    Site
    Collaborative Neuroscience Network - CNS, Los Alamitos, California
    Locations
    13 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06657768 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.